维力医疗收盘下跌2.08%，滚动市盈率18.25倍，总市值42.79亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Weili Medical, indicating a decline in stock price and a relatively low PE ratio compared to the industry average [1][2] - As of August 22, Weili Medical's stock closed at 14.61 yuan, down 2.08%, with a rolling PE ratio of 18.25 times and a total market capitalization of 4.279 billion yuan [1] - The medical device industry has an average PE ratio of 56.95 times and a median of 40.49 times, positioning Weili Medical at 41st in the industry ranking [1][2] Group 2 - As of the 2025 semi-annual report, 16 institutions hold shares in Weili Medical, including 8 funds, 6 others, 1 social security fund, and 1 insurance company, with a total shareholding of 161.66 million shares valued at 2.056 billion yuan [1] - Weili Medical specializes in the research, production, and sales of medical catheters in fields such as anesthesia, urology, respiratory care, and hemodialysis, with key products including various types of intubation tubes and drainage bags [1] - The latest performance report shows that for the first half of 2025, Weili Medical achieved an operating income of 745 million yuan, a year-on-year increase of 10.19%, and a net profit of 121 million yuan, up 14.17%, with a gross profit margin of 45.04% [1]